Company: TBPH
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001558370-25-007398
Chunk: 3

Company: Theravance Biopharma, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
 outstanding​  —​​ —Ordinary shares, $0.00001 par value per share: 200,000 shares authorized; 50,001 and 49,471 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively​  1​​ —Additional paid-in capital​  1,145,083​​ 1,141,060Accumulated other comprehensive income​  —​  7Accumulated deficit ​  (979,101)​  (965,522)Total shareholders’ equity​  165,983​  175,545Total liabilities and shareholders’ equity​$ 343,582​$ 354,161

​

​

See accompanying notes to condensed consolidated financial statements.

​